Skip to main content

Table 2 Comparison results of the progressive and non-progressive groups in terms of biochemical and CACS values

From: FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients

 

Progressive (n = 36)

Non-progressive (n = 38)

p value

Age (years)

56 ± 13

48 ± 14

0.02

Time on dialysis (months)*

64 (23–98)

48 (22–84)

0.23

Kt/V

1.43 ± 0.43

1.44 ± 0.48

0.82

Vitamin D dose (μg/week)*

1.50 (0–2.50)

1.20 (0.11-2.31)

0.91

Calcium (mg/dL)

9.56 ± 0.79

9.38 ± 0.64

0.29

Phosphorus (mg/dL)

5.92 ± 1.63

4.99 ± 1.25

0.008

Ca X P (mg2/dL2)

56.71 ± 16.77

46.69 ± 11.56

0.004

Alkaline phosphatase (U/L)*

116 (82–177)

115 (81–192)

0.80

PTH (pg/mL)*

468 (233–648)

401 (249–610)

0.15

Uric acid (mg/dL)

6.47 ± 1.13

6.42 ± 1.29

0.85

Albumin (g/dL)

3.87 ± 0.30

3.96 ± 0.26

0.15

C-reactive protein (mg/L)*

8.70 (2.70-19.10)

7.40 (2.80-17.60)

0.64

Triglyceride (mg/dL)*

145 (101–209)

150 (101–225)

0.20

Cholesterol (mg/dL)

190 ± 55

195 ± 47

0.69

FGF-23 (pg/mL)*

155 (80–468)

147 (82–234)

0.04

CACS (baseline)*

190 (52–935)

4 (0.30-290)

<0.001

CACS (1st year)*

543 (123–1025)

1.80 (0.65-41)

<0.001

  1. (FGF-23: fibroblast growth factor-23, CACS: coronary artery calcification score, PTH: parathyroid hormone) *Median (IQR).